OrionShield Bonus 7-Year review

It depends on your commitment level and how you weigh the bonus math. If you're certain you won't touch the principal for seven-plus years and you want an immediate account-value credit, this is a reasonable choice within its peer group. If you might need more than 10% in any given year, or if you're uncertain about the full-term commitment, the reduced crediting rates plus slow bonus vesting tip the balance against it. I think it's a solid product for the right buyer, but the right buyer is more specific than the bonus headline implies.

The clearest reason to buy OrionShield Bonus 7-Year is the 5% premium bonus. It lands in your account value on day one, which means your starting balance for index crediting purposes is higher from the outset. For a buyer putting in $100,000, that's $105,000 working in the contract immediately. The secondary reason is the index menu — seven index options including several low-volatility managed indices with participation rates well above 100% — which gives buyers flexibility to position for different market environments without taking on direct equity risk.

I think this product is best for a buyer in their mid-50s to early 70s who is moving qualified or non-qualified money into a tax-deferred accumulation vehicle with a genuine 7-year or longer horizon. It's a better fit for someone who prioritizes the upfront growth credit over maximum annual crediting potential, and who is comfortable with the fact that the premium bonus comes at the cost of lower caps and participation rates going forward. It is less suited for someone who values liquidity flexibility, is shopping primarily for income-rider benefits, or wants the highest possible crediting rates on each index strategy.

You are buying principal protection with deferred growth potential, plus an upfront account-value credit. The premium bonus is not free money — it is a structural tradeoff where AuguStar increases your starting balance in exchange for offering you lower ongoing crediting rates on the indexed strategies. The real question is whether the bonus, compounded over the surrender period, outperforms what you would have earned with higher rates and no bonus on an otherwise comparable contract. That answer depends on which indices you use, when the bonus fully vests, and whether you hold to term. The contract itself carries no annual product fee, no M&E charge, and no administration fee, which helps the math on the bonus version relative to products that layer fees on top.

OrionShield Bonus 7-Year credits a 5% premium bonus to your account value at contract issue, subject to the election of what the brochure calls the "7-Year OrionShield Level 1" option. The bonus is immediately reflected in your account value — it is not a benefit-base bonus on a rider, it is actual credited cash value. However, the bonus vests over time: in years 1 and 2 you are entitled to 0% of the bonus if you take excess withdrawals; vesting steps up gradually through year 7 (0.25%, 0.75%, 1.25%, 2.00%, 3.00%, 4.00% respectively) and reaches 5.00% only after year 8. Withdrawals in excess of the 10% free amount during years 1-7 trigger pro-rata forfeiture of the unvested portion on top of any surrender charge and MVA. At death, the full 5% bonus is considered fully vested regardless of contract year.

For indexed crediting, the contract offers seven index choices. The S&P 500 uses a cap-rate annual point-to-point strategy — cap rates were 5.25% for under $150,000 and 6.25% at $150,000 or more as of the November 2025 rate sheet, which is relatively modest. The six remaining indices use participation-rate strategies, and several of these are managed or volatility-controlled indices with participation rates well above 100% — particularly the S&P 500 MARC 5 (136%/152%), Multi-Asset Dynamic Managed 5 (146%/163%), and Strategic Dynamic Balanced Asset 8 (92%/103%). Those participation rates are high on paper, but these indices are specifically designed to generate less raw movement than standard equity benchmarks, so a high participation rate on a low-volatility index doesn't always outperform a lower participation rate on a more active one.

The nursing home confinement waiver is the secondary feature worth understanding. If you are confined to a nursing home for at least 60 days, the contract waives surrender charges and the MVA on withdrawals — a meaningful liquidity safety valve for buyers who are funding this with retirement savings they might need if health events change their situation. The death benefit also gets special treatment: at death, the full 5% bonus is immediately vested and the beneficiary receives the greater of the full account value or the minimum guaranteed surrender value. That provision gives some protection against the scenario where you die before the bonus finishes vesting.

The surrender schedule starts high at 9% in year one and steps down to 3% in year 7, clearing in year 8. That's a steeper starting penalty than many 7-year FIAs, which commonly open at 7% or 8%. In practical terms, this is not a product you buy expecting to access the principal in the near term — the 9% charge plus an MVA in year one would represent a significant loss of account value on top of any unvested bonus forfeiture.

The 10% free withdrawal provision kicks in after year one and applies to the account value at the prior anniversary — a standard provision. AuguStar also applies an MVA (Market Value Adjustment) to surrenders and excess withdrawals during the charge period, meaning your effective surrender cost fluctuates with interest rate movements at the time of the withdrawal. In rising-rate environments, the MVA can work against you; in falling-rate environments, it can reduce the penalty. It is a real factor and worth factoring into planning for anyone who might exit early.

For RMD treatment, the brochure did not explicitly specify whether RMDs are exempt from surrender charges — this is a gap worth confirming with AuguStar directly if you are funding this with IRA assets.

There is no annual contract fee, no administration charge, and no M&E charge — the base product is fee-free. That's a genuine benefit and helps the bonus version's overall math relative to products that charge 0.25%–0.50% annually on top of a bonus structure.

The cost of the premium bonus is carried in the crediting rates. The brochure is explicit about this: electing the bonus results in lower caps and participation rates than you would get on a non-bonus version. Over a 7-year term, the drag from reduced crediting rates can outweigh the upfront 5% credit, depending on index performance and which strategies you use. This isn't a criticism unique to AuguStar — it's the structural reality of all bonus FIAs — but it means the bonus is not a guaranteed windfall.

The other tradeoff is the vesting schedule. If you surrender in year 5 with only 2% of the bonus vested, your bonus recapture is 3% of the original premium, on top of a 5% surrender charge and potential MVA. That's meaningful erosion on an early exit.

Legal Entity: AuguStar Life Insurance Company

Parent: Constellation Insurance

A.M. Best Rating: A

AuguStar Life is the insurance operating entity under Constellation Insurance, a holding company that also owns other regional carriers. The A.M. Best A rating is a solid tier — not top-of-market, but well within the range buyers typically require for a long-term annuity contract. AuguStar is not one of the largest national carriers by distribution volume, which means it may be less familiar to buyers accustomed to household names, but the financial strength rating is the relevant benchmark for an insurance obligation of this type.